Gastric cancer (GC) is the 4th most common human malignant disease and the second-leading cancer-related deaths in the world(DeManzoni et al., 2016). Treatment with 5-fluorouracil/oxaliplatin (5-FU/oxaliplatin) chemotherapy has proven to significantly improve survivalof patients with metastatic GC
PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy / Sobhani, Navid; Generali, Daniele; Roviello, Giandomenico. - In: EBIOMEDICINE. - ISSN 2352-3964. - 22:(2017), pp. 18-19. [10.1016/j.ebiom.2017.07.003]
PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy
Roviello, Giandomenico
2017
Abstract
Gastric cancer (GC) is the 4th most common human malignant disease and the second-leading cancer-related deaths in the world(DeManzoni et al., 2016). Treatment with 5-fluorouracil/oxaliplatin (5-FU/oxaliplatin) chemotherapy has proven to significantly improve survivalof patients with metastatic GC
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
PIIS2352396417302669.pdf
Accesso chiuso
Dimensione
141.42 kB
Formato
Adobe PDF
|
141.42 kB | Adobe PDF | Richiedi una copia |
|
1-s2.0-S2352396417302669-main.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
141.42 kB
Formato
Adobe PDF
|
141.42 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
